Mike Hennessy Jr.

A coordinated and international response is needed to help control the latest mpox outbreak in Africa.

Will Sanofi’s plan to recruit the younger generation through its participation in the upcoming 2024 Olympic and Paralympic Games, being held in Paris, pay off?

Improved efficiencies and reduced costs are clear advantages of automating drug manufacturing processes.

Technological advances are helping advance biologics development and manufacturing and reduce bottlenecks.

Experts believe it is likely cancer cells are more common in the body than previously thought, but typically caught early and removed in the body’s cancer-immune cycle. When the system is in good working order (and protecting us), dead cancer cells release neoantigens.

While Catalent’s acquisition is definitely about making drugs, it’s also very much about making money.

Given its positioning at each new year’s commencement, the J.P. Morgan Healthcare conference helps establish the tone with which the pharmaceutical industry is viewed.

GSI shortages result from how hospitals buy GSI drugs, and the underinvestment in manufacturing operations that follow.

Pharmaceuticals are entering a transition into a far more complex era of patient therapies, and patient segmentation.

Industry investments indicate increasing trust in the newest modalities, including mRNA approaches.